Business Times DC
SEE OTHER BRANDS

The latest business and economy news from Washington, D.C.

Business Times DC: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Business Times DC.

Press releases published on May 8, 2025

SIGA Reports Financial Results for Three Months Ended March 31, 2025

SIGA Reports Financial Results for Three Months Ended March 31, 2025

Received $26 Million IV TPOXX Procurement Order from the U.S. Government in March $94 million in TPOXX Orders (to be Delivered to U.S. Strategic National Stockpile) outstanding as of March 31, 2025 Corporate Update Conference Call Today at 4:30 PM ET NEW …

The RealReal Announces First Quarter 2025 Results

The RealReal Announces First Quarter 2025 Results

Q1 2025 Revenue of $160 million, up 11% Year-Over-Year Q1 2025 Net Income of $62 million including $80 million of non-cash gains Q1 2025 Adjusted EBITDA of $4.1 million improved $6.4 million Year-Over-Year SAN FRANCISCO, May 08, 2025 (GLOBE NEWSWIRE) -- …

Elutia Announces Strong First Quarter 2025 Financial Results Driven by 84% Sequential Growth in EluPro™ Sales

Elutia Announces Strong First Quarter 2025 Financial Results Driven by 84% Sequential Growth in EluPro™ Sales

- New Boston Scientific distribution partnership now underway - - Conference call today at 5:00 p.m. ET / 2:00 p.m. PT - SILVER SPRING, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting …

BeautyHealth Reports First Quarter 2025 Financial Results

BeautyHealth Reports First Quarter 2025 Financial Results

LONG BEACH, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ: SKIN) (“BeautyHealth” or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the first quarter ended March 31, 2025 (“Q1 2025”). “ …

Inseego Reports First Quarter 2025 Financial Results

Inseego Reports First Quarter 2025 Financial Results

Q1 2025 revenue of $31.7 million Q1 2025 positive Adjusted EBITDA of $3.7 million and GAAP Net Loss of $1.6 million Ninth consecutive quarter of positive Adjusted EBITDA SAN DIEGO, May 08, 2025 (GLOBE NEWSWIRE) -- Inseego Corp. (Nasdaq: INSG) (the “Company …

Brilliant Earth Announces Participation in B. Riley Securities 25th Annual Investor Conference

Brilliant Earth Announces Participation in B. Riley Securities 25th Annual Investor Conference

SAN FRANCISCO, May 08, 2025 (GLOBE NEWSWIRE) -- Brilliant Earth Group, Inc. (“Brilliant Earth” or the “Company”) (NASDAQ: BRLT), an innovative, global leader in ethically sourced fine jewelry, today announced that the Company will participate in the B. …

Aqua Metals Expands Product Platform with Advancements in Nickel, MHP, and LFP Recycling; Reports First Quarter 2025 Results

Aqua Metals Expands Product Platform with Advancements in Nickel, MHP, and LFP Recycling; Reports First Quarter 2025 Results

RENO, Nev., May 08, 2025 (GLOBE NEWSWIRE) -- Aqua Metals (NASDAQ: AQMS), an innovator in domestic critical minerals refining, AquaRefining™, today reported financial results for the first quarter ended March 31, 2025, and highlighted major technology and …

Profound Medical Announces First Quarter 2025 Financial Results

Profound Medical Announces First Quarter 2025 Financial Results

TORONTO, May 08, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, AI-powered, incision-free therapies for the ablation of …

MARA Announces First Quarter 2025 Results

MARA Announces First Quarter 2025 Results

Revenues increased 30% YoY to $214 million Bitcoin holdings increased 174% YoY to 47,531 from 17,320 at the end of Q1 2024 Fort Lauderdale, FL, May 08, 2025 (GLOBE NEWSWIRE) -- MARA Holdings, Inc. (NASDAQ: MARA) ("MARA" or the "Company"), a vertically …

Oportun Reports First Quarter 2025 Financial Results

Oportun Reports First Quarter 2025 Financial Results

GAAP Net income of $9.8 million increased $36 million year-over-year GAAP EPS of $0.21 increased $0.89 year-over-year Adjusted EPS of $0.40 increased $0.31 year-over-year Operating expenses of $93 million reduced 15% year-over-year Reiterating full year …

Soleno Therapeutics Announces Oral Presentations Featuring VYKAT(TM) XR in Prader-Willi Syndrome at ESPE and ESE 2025

Soleno Therapeutics Announces Oral Presentations Featuring VYKAT(TM) XR in Prader-Willi Syndrome at ESPE and ESE 2025

REDWOOD CITY, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that it will present data from its …

ICU Medical Announces First Quarter 2025 Results

ICU Medical Announces First Quarter 2025 Results

SAN CLEMENTE, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended March 31, 2025. First …

FAT BRANDS INC. REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS

FAT BRANDS INC. REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS

Conference call and webcast today at 5:30 p.m. ET LOS ANGELES, May 08, 2025 (GLOBE NEWSWIRE) -- FAT (Fresh. Authentic. Tasty.) Brands Inc. (NASDAQ: FAT) (“FAT Brands” or the “Company”) today reported financial results for the fiscal first quarter ended …

Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results

Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results

Activities supporting the close out of BEACON-IPF continue; topline data expected in the second quarter of 2025 Recently announced strategic realignment of workforce and operations will extend cash runway to support execution of late-stage clinical trials …

La Croix-Rouge canadienne insiste sur la nécessité de protéger le personnel humanitaire après un nombre record de décès en 2024

La Croix-Rouge canadienne insiste sur la nécessité de protéger le personnel humanitaire après un nombre record de décès en 2024

OTTAWA, Ontario, 08 mai 2025 (GLOBE NEWSWIRE) -- À l’occasion de la Journée de la Croix-Rouge et du Croissant-Rouge, la Croix-Rouge canadienne appelle à la protection du personnel humanitaire dans le monde entier. Déjà, cette année, le Mouvement …

Texas Roadhouse, Inc. Announces First Quarter 2025 Results

Texas Roadhouse, Inc. Announces First Quarter 2025 Results

LOUISVILLE, KY., May 08, 2025 (GLOBE NEWSWIRE) -- Texas Roadhouse, Inc. (NasdaqGS: TXRH), today announced financial results for the 13 weeks ended April 1, 2025. Financial Results Financial results for the 13 weeks ended April 1, 2025 and March 26, 2024 …

Nanox to Report First Quarter 2025 Financial Results on May 22, 2025

Nanox to Report First Quarter 2025 Financial Results on May 22, 2025

PETACH TIKVA, Israel, May 08, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended March 31, …

AVITA Medical Reports First Quarter 2025 Financial Results

AVITA Medical Reports First Quarter 2025 Financial Results

VALENCIA, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today reported financial results for the first quarter ended March 31, 2025 …

PDF Solutions® Announces First Quarter 2025 Financial Results

PDF Solutions® Announces First Quarter 2025 Financial Results

SANTA CLARA, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- PDF Solutions, Inc. (Nasdaq: PDFS), a leading provider of comprehensive data solutions for the semiconductor and electronics ecosystem, today announced financial results for its first quarter ended …

Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2025 Financial Results

Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2025 Financial Results

Soquelitinib data from cohorts 1-3 of atopic dermatitis Phase 1 clinical trial demonstrate favorable safety and efficacy profile, including earlier and deeper responses in cohort 3 compared to cohorts 1-2 Phase 3 registrational clinical trial of …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service